Literature DB >> 34110404

Checkpoint-blocked T cells checkmate AML.

Kirsten M Williams1.   

Abstract

Entities:  

Keywords:  Basic Biology; CHEMOKINES; Chemokines; IMMUNOBIOLOGY; MARROW AND STEM CELL TRANSPLANTATION; Myeloid Leukemias and Dysplasias: Immunotherapeutic approaches; NEOPLASIA; Tumor immunology

Mesh：

Year:  2021        PMID： 34110404      PMCID： PMC8351895          DOI： 10.1182/blood.2021011497

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   25.476


× No keyword cloud information.
  10 in total

1.  Ipilimumab for Patients with Relapse after Allogeneic Transplantation.

Authors:  Matthew S Davids; Haesook T Kim; Pavan Bachireddy; Caitlin Costello; Rebecca Liguori; Alexandra Savell; Alexander P Lukez; David Avigan; Yi-Bin Chen; Peter McSweeney; Nicole R LeBoeuf; Michael S Rooney; Michaela Bowden; Chensheng W Zhou; Scott R Granter; Jason L Hornick; Scott J Rodig; Masahiro Hirakawa; Mariano Severgnini; F Stephen Hodi; Catherine J Wu; Vincent T Ho; Corey Cutler; John Koreth; Edwin P Alyea; Joseph H Antin; Philippe Armand; Howard Streicher; Edward D Ball; Jerome Ritz; Asad Bashey; Robert J Soiffer
Journal:  N Engl J Med       Date:  2016-07-14       Impact factor: 91.245

Review 2.  Harnessing the immune system after allogeneic stem cell transplant in acute myeloid leukemia.

Authors:  Cole Sterling; Jonathan Webster
Journal:  Am J Hematol       Date:  2020-02-19       Impact factor: 10.047

Review 3.  The Role of Antigen Spreading in the Efficacy of Immunotherapies.

Authors:  Peter Brossart
Journal:  Clin Cancer Res       Date:  2020-05-01       Impact factor: 12.531

4.  A multicenter phase 1 study of nivolumab for relapsed hematologic malignancies after allogeneic transplantation.

Authors:  Matthew S Davids; Haesook T Kim; Caitlin Costello; Alex F Herrera; Frederick L Locke; Rodrigo O Maegawa; Alexandra Savell; Michael Mazzeo; Adrienne Anderson; Alexander P Boardman; Augustine Weber; David Avigan; Yi-Bin Chen; Sarah Nikiforow; Vincent T Ho; Corey Cutler; Edwin P Alyea; Pavan Bachireddy; Catherine J Wu; Jerome Ritz; Howard Streicher; Edward D Ball; Asad Bashey; Robert J Soiffer; Philippe Armand
Journal:  Blood       Date:  2020-06-11       Impact factor: 22.113

5.  Graft-versus-leukemia reactions after bone marrow transplantation.

Authors:  M M Horowitz; R P Gale; P M Sondel; J M Goldman; J Kersey; H J Kolb; A A Rimm; O Ringdén; C Rozman; B Speck
Journal:  Blood       Date:  1990-02-01       Impact factor: 22.113

Review 6.  Graft-versus-disease effect following allogeneic transplantation for acute leukaemia.

Authors:  Jacob M Rowe
Journal:  Best Pract Res Clin Haematol       Date:  2008-09       Impact factor: 3.020

Review 7.  Checkpoint inhibitors and acute myelogenous leukemia: promises and challenges.

Authors:  Mansour Alfayez; Gautam Borthakur
Journal:  Expert Rev Hematol       Date:  2018-05       Impact factor: 2.929

Review 8.  Graft-versus-host disease versus graft-versus-leukemia.

Authors:  Robert S Negrin
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2015

Review 9.  Checkpoint inhibitors in AML: are we there yet?

Authors:  Arnab Ghosh; Pere Barba; Miguel-Angel Perales
Journal:  Br J Haematol       Date:  2019-12-06       Impact factor: 8.615

10.  Molecular and cellular features of CTLA-4 blockade for relapsed myeloid malignancies after transplantation.

Authors:  Livius Penter; Yi Zhang; Alexandra Savell; Teddy Huang; Nicoletta Cieri; Emily M Thrash; Seunghee Kim-Schulze; Aashna Jhaveri; Jingxin Fu; Srinika Ranasinghe; Shuqiang Li; Wandi Zhang; Emma S Hathaway; Matthew Nazzaro; Haesook T Kim; Helen Chen; Magdalena Thurin; Scott J Rodig; Mariano Severgnini; Carrie Cibulskis; Stacey Gabriel; Kenneth J Livak; Corey Cutler; Joseph H Antin; Sarah Nikiforow; John Koreth; Vincent T Ho; Philippe Armand; Jerome Ritz; Howard Streicher; Donna Neuberg; F Stephen Hodi; Sacha Gnjatic; Robert J Soiffer; X Shirley Liu; Matthew S Davids; Pavan Bachireddy; Catherine J Wu
Journal:  Blood       Date:  2021-06-10       Impact factor: 25.476
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.